Hipercolesterolemia familiar en Gran Canaria: mutación con efecto fundador y alta frecuencia de diabetes

Sánchez-Hernández, Rosa M; González-Lleó, Ana M; Tugores, Antonio; Brito-Casillas, Yeray; Civeira, Fernando; Boronat, Mauro; Wägner, Ana.
Clín. investig. arterioscler. (Ed. impr.) ; 33(5): 247-253, Sep-Oct. 2021. tab
Artículo en Español | IBECS (España) | ID: ibc-221048

Documentos relacionados

  1. Familial hypercholesterolemia in Gran Canaria: Founder mutation effect and high frequency of diabetes.
  2. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study.
  3. Additive Effect of <i>APOE</i> Rare Variants on the Phenotype of Familial Hypercholesterolemia.
  4. Analysis of Clinical and Biochemical Characteristics of Patients With Genetically Confirmed Familial Hypercholesterolemia in Russian North Western District Residents.
  5. Genetic identification of familial hypercholesterolemia within whole genome sequences in 6820 newborns.
  6. Prevalence of FH-Causing Variants and Impact on LDL-C Concentration in European, South Asian, and African Ancestry Groups of the UK Biobank-Brief Report.
  7. High Prevalence of Familial Hypercholesterolemia Due to the Founder Effect of the LDLR c.2271del Variant in Communities of Oaxaca, Mexico.
  8. Establishing non-fasting reference values for plasma lipids levels based on age, sex, and puberty stage in a French-Canadian pediatric population.
  9. Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease.
  10. Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study.